#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Extra-osseous Ewing's sarcoma metastatic Hyperphagia Chronic kidney disease Kidney transplant rejection Oropharyngeal squamous cell carcinoma Thermal burn Arginase deficiency Neuronal ceroid lipofuscinosis Neurofibromatosis Myelodysplastic syndrome Hereditary neuropathic amyloidosis Scedosporium infection Malignant fibrous histiocytoma B precursor type acute leukaemia T-cell type acute leukaemia More trials…

    Learn about Rare Diseases

    Noonan syndrome – Treatment Aicardi-Goutieres syndrome – Treatment Combined immunodeficiency – Life with Disease Cerebral arteriovenous malformation haemorrhagic – Diagnostics Skin angiosarcoma – Basic Information Rosai-Dorfman syndrome – Basic Information Urea cycle disorder – Treatment Ewing’s sarcoma recurrent – Basic Information Hereditary neuropathic amyloidosis – Diagnostics Angiosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Hydrogen Carbonate Nipocalimab Indacaterol Mps-103 AUROCELL-TX GSKVX000000034796 Metyrapone Bp Pyruvic Acid Lacosamide Dexrazoxane Sodium Nitrite Imifoplatin Cenegermin Liraglutide Nnc0194-0499 Axicabtagene Ciloleucel Ly3537982 Acetylsalicylic Acid Azd7798 Empasiprubart More therapies…

    Learn about Your Condition

    IgA nephropathy Drug dependence Neonatal anoxia Haematological infection Haemodialysis Hypoalbuminaemia Malignant fibrous histiocytoma Fibrous dysplasia of bone Thromboangiitis obliterans Pharyngeal cancer stage I Toxic nodular goitre Oropharyngeal cancer recurrent White matter lesion Nocturia Bone sarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Parkinson’s disease

  • Study on the Use of 18F-PI-2620 for Patients with Progressive Supranuclear Palsy and Parkinson’s Disease

    Recruiting

    2 1 1
    Investigated Diseases:
    • Progressive supranuclear palsy
    • Parkinson’s disease
    Investigated Drugs:
    • Izaflortaucipir (18F)
    Spain

  • A study using [11C]ORM-13070 to examine the effects of aging and Parkinson’s disease on specific brain receptors.

    Recruiting

    2 1 1
    Investigated Drugs:
    • 1-[[(3S)-2,3-DIHYDRO-1,4-BENZODIOXIN-3-YL]METHYL]-4-[3-((11C)METHOXYMETHYL)-2-PYRIDINYL]PIPERAZINE
    France

  • A study comparing prasinezumab with placebo for people with early-stage Parkinson’s disease

    Recruiting

    3 1
    Investigated Drugs:
    • Prasinezumab
    Austria Denmark France Germany Italy The Netherlands +3

  • A Study Testing SUL-238 in Patients with Early, Untreated Parkinson’s Disease to Assess Effects on Brain Energy Metabolism

    Recruiting

    2 1
    The Netherlands

  • A Study Testing the Safety of IRL757 in Adults with Parkinson’s Disease Who Have Apathy

    Recruiting

    1 1
    Investigated Diseases:
    • Parkinson’s disease
    Bulgaria Germany Poland Spain

  • A Study Testing if Daily Tadalafil Improves Movement Symptoms in Patients with Early-Stage Parkinson’s Disease Who Have Not Yet Started Treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Tadalafil
    The Netherlands
1 2 3 … 10
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!